Clinical trial
Evaluation of Ubiquinol on the Association of Statins and Mitochondrial Oxidative Capacity Using 31P Magnetic Resonance Imaging
NCT01702987 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Ubiquinol on the Association of Statins and Mitochondrial Oxidative Capacity Using 31P Magnetic Resonance Imaging
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- October 31, 2013
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hmg coa reductase inhibitor adverse reaction, hypercholesterolemia, myopathy